文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

妊娠期重症新型冠状病毒肺炎:对101例病例队列通气结局的评估

Severe COVID-19 in pregnancy: evaluation of ventilatory outcomes on a 101-cases cohort.

作者信息

Mendes Isabel Cristina Melo, Oliveira Ana Luiza Martins de, Trindade Priscila Martins Pinheiro, Rodrigues Glaucia de Melo, Pimentel Clarisse, Escosteguy Claudia Caminha, Galliez Rafael Mello

机构信息

Universidade Federal do Rio de Janeiro, Programa de Pós-Graduação em Doenças Infecciosas e Parasitárias, Rio de Janeiro, Rio de Janeiro, Brazil.

Instituto Estadual de Infectologia São Sebastião, Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Rev Inst Med Trop Sao Paulo. 2025 Aug 18;67:e51. doi: 10.1590/S1678-9946202567051. eCollection 2025.


DOI:10.1590/S1678-9946202567051
PMID:40834144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12364485/
Abstract

Pregnant and postpartum women are considered at increased risk for severe COVID-19. However, information about disease progression and management in this population is scarce. This study aims to describe sociodemographic, clinical, and radiological characteristics of pregnant and postpartum women admitted to intensive care due to severe COVID-19, emphasizing respiratory outcomes. This is a retrospective, descriptive cohort study evaluating consecutive admissions of pregnant and postpartum women to an infectious diseases intensive care unit due to confirmed or suspected COVID-19, from May 2020 to June 2022. Numerical variables were described by median and interquartile range (IQR), and categorical variables, by frequency and percentage. Missing data were excluded from the analysis. A total of 101 admissions were recorded (85 pregnant and 16 postpartum women), with most patients in their second or third trimester. Forty-seven women (46.5%) required invasive mechanical ventilation (IMV), most of whom (62.1%) showed at least 50% of lung involvement on CT scans and requiring neuromuscular blocking agents (89.1%). Lethality was 15.8% in the cohort and 34.0% among women who required IMV. Pregnant and postpartum women are at risk of developing severe COVID-19, with high mortality and need for IMV and neuromuscular blocking. They should be prioritized in public health policies addressing COVID-19.

摘要

孕妇和产后妇女被认为感染重症新型冠状病毒肺炎(COVID-19)的风险增加。然而,关于这一人群疾病进展和管理的信息却很匮乏。本研究旨在描述因重症COVID-19入住重症监护病房的孕妇和产后妇女的社会人口学、临床和放射学特征,重点关注呼吸结局。这是一项回顾性描述性队列研究,评估了2020年5月至2022年6月期间因确诊或疑似COVID-19连续入住传染病重症监护病房的孕妇和产后妇女。数值变量用中位数和四分位数间距(IQR)描述,分类变量用频率和百分比描述。分析中排除缺失数据。共记录了101例入院病例(85例孕妇和16例产后妇女),大多数患者处于妊娠中期或晚期。47名妇女(46.5%)需要有创机械通气(IMV),其中大多数(62.1%)在CT扫描中显示肺部受累至少50%,并需要使用神经肌肉阻滞剂(89.1%)。该队列的死亡率为15.8%,需要IMV的妇女中死亡率为34.0%。孕妇和产后妇女有发生重症COVID-19的风险,死亡率高,需要IMV和神经肌肉阻滞剂。在应对COVID-19的公共卫生政策中,应将她们作为优先考虑对象。

相似文献

[1]
Severe COVID-19 in pregnancy: evaluation of ventilatory outcomes on a 101-cases cohort.

Rev Inst Med Trop Sao Paulo. 2025-8-18

[2]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[3]
Outcomes of pregnant and post-partum patients admitted to the intensive care unit with COVID-19 in Australia: An analysis of SPRINT-SARI Australia.

Aust N Z J Obstet Gynaecol. 2025-6

[4]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[5]
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Cochrane Database Syst Rev. 2021-9-2

[6]
Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19.

Cochrane Database Syst Rev. 2022-6-29

[7]
Clinical and epidemiological profile of pregnant and postpartum women affected by COVID-19 who required respiratory support.

Rev Bras Ginecol Obstet. 2025-4-30

[8]
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Cochrane Database Syst Rev. 2010-3-17

[9]
SARS-CoV-2 Infection and Adverse Maternal and Perinatal Outcomes: Time-to-Event Analysis of a Hospital-Based Cohort Study of Pregnant Women in Rio de Janeiro, Brazil.

Viruses. 2025-1-31

[10]
Impact of Gamma COVID-19 variant on the prognosis of hospitalized pregnant and postpartum women with cardiovascular disease.

Clinics (Sao Paulo). 2024

本文引用的文献

[1]
A review of COVID-19 therapeutics in pregnancy and lactation.

Obstet Med. 2022-12

[2]
Treatment of pregnant and early postpartum women with severe and critical COVID-19: experience at a tertiary center.

Eur J Med Res. 2022-12-2

[3]
The COVID-19 pandemic in Brazilian pregnant and postpartum women: results from the REBRACO prospective cohort study.

Sci Rep. 2022-7-11

[4]
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?

Int J Environ Res Public Health. 2022-4-11

[5]
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.

BMJ. 2022-3-9

[6]
Extracorporeal membrane oxygenation outcomes in COVID-19 patients: Case series from the Brazilian COVID-19 Registry.

Artif Organs. 2022-5

[7]
COVID-19 Delta Variant-of-Concern: A Real Concern for Pregnant Women With Gestational Diabetes Mellitus.

Front Endocrinol (Lausanne). 2021-11-15

[8]
A review of remdesivir for COVID-19 in pregnancy and lactation.

J Antimicrob Chemother. 2021-12-24

[9]
Obstetric Observatory BRAZIL - COVID-19: 1031 maternal deaths because of COVID-19 and the unequal access to health care services.

Clinics (Sao Paulo). 2021-6-28

[10]
COVID-19 poses alarming pregnancy and postpartum mortality risk in Brazil.

EClinicalMedicine. 2021-5-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索